Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Veterinary Dermatology Drugs Market, By Product Type
7.1. Veterinary Dermatology Drugs Market, by Product Type, 2021-2030
7.1.1. Antifungal Drugs
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Antibacterial Drugs
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Antiparasitic Drugs
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Others
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Veterinary Dermatology Drugs Market, By Mode of Administration
8.1. Veterinary Dermatology Drugs Market, by Mode of Administration, 2021-2030
8.1.1. Topical
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Oral
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Injectable
8.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Veterinary Dermatology Drugs Market, By Animal Type
9.1. Veterinary Dermatology Drugs Market, by Animal Type, 2021-2030
9.1.1. Large Animals
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Small Animals
9.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 10.Global Veterinary Dermatology Drugs Market, By Indication
10.1. Veterinary Dermatology Drugs Market, by Indication, 2021-2030
10.1.1. Infectious Diseases
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Skin Cancer
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Autoimmune Skin Diseases
10.1.3.1. Market Revenue and Forecast (2016-2030)
10.1.4. Parasitic Infections
10.1.4.1. Market Revenue and Forecast (2016-2030)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 11.Global Veterinary Dermatology Drugs Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.1.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.1.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.1.4. Market Revenue and Forecast, by Indication (2016-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.1.5.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.1.5.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.1.5.4. Market Revenue and Forecast, by Indication (2016-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.1.6.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.1.6.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.1.6.4. Market Revenue and Forecast, by Indication (2016-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.2.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.2.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.2.4. Market Revenue and Forecast, by Indication (2016-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.2.5.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.2.5.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.2.5.4. Market Revenue and Forecast, by Indication (2016-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.2.6.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.2.6.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.2.6.4. Market Revenue and Forecast, by Indication (2016-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.2.7.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.2.7.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.2.7.4. Market Revenue and Forecast, by Indication (2016-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.2.8.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.2.8.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.2.8.4. Market Revenue and Forecast, by Indication (2016-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.3.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.3.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.3.4. Market Revenue and Forecast, by Indication (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.3.5.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.3.5.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.3.5.4. Market Revenue and Forecast, by Indication (2016-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.3.6.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.3.6.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.3.6.4. Market Revenue and Forecast, by Indication (2016-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.3.7.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.3.7.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.3.7.4. Market Revenue and Forecast, by Indication (2016-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.3.8.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.3.8.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.3.8.4. Market Revenue and Forecast, by Indication (2016-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.4.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.4.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.4.4. Market Revenue and Forecast, by Indication (2016-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.4.5.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.4.5.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.4.5.4. Market Revenue and Forecast, by Indication (2016-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.4.6.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.4.6.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.4.6.4. Market Revenue and Forecast, by Indication (2016-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.4.7.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.4.7.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.4.7.4. Market Revenue and Forecast, by Indication (2016-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.4.8.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.4.8.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.4.8.4. Market Revenue and Forecast, by Indication (2016-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.5.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.5.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.5.4. Market Revenue and Forecast, by Indication (2016-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.5.5.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.5.5.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.5.5.4. Market Revenue and Forecast, by Indication (2016-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product Type (2016-2030)
11.5.6.2. Market Revenue and Forecast, by Mode of Administration (2016-2030)
11.5.6.3. Market Revenue and Forecast, by Animal Type (2016-2030)
11.5.6.4. Market Revenue and Forecast, by Indication (2016-2030)
Chapter 12. Company Profiles
12.1. Merial, Zoetis, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Ceva Sante Animale
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Vetmedica
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. IDEXX Laboratories
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Vetoquinol S.A.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Virbac S.A.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Bayer Animal Health
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Boehringer Ingelheim
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Elanco
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Novartis Animal Health
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. SAVAVET
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms